Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
暂无分享,去创建一个
R. Mansel | E. Rutgers | J. Bogaerts | C. V. D. van de Velde | G. Tienhoven | G. Nieuwenhuijzen | T. van Dalen | W. H. Bouma | H. Rijna | L. Slaets | P. W. Graaf | M. Snoj | M. Straver | N. Duez | N. Bundred | C. Coens | P. D. de Graaf | L. Cataliotti | M. Donker | G. van Tienhoven | P. Meijnen | A. H. Westenberg | J. Klinkenbijl | L. Orzalesi | H. V. D. van der Mijle | S. Veltkamp | A. Marinelli | J. Merkus | Y. Belkacemi | P. Petignat | D. Schinagl | C. Messina | T. Dalen | C. Velde | Huub van der Mijle
[1] A. Luini,et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.
[2] K. Hunt,et al. Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Giuliano,et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.
[4] S. Fosså,et al. The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study , 2010, Journal of cancer survivorship : research and practice.
[5] Kelly K. Hunt,et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. , 2010, Annals of surgery.
[6] T. Julian,et al. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Norman Wolmark,et al. Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection , 2010, Journal of surgical oncology.
[8] E. Rutgers,et al. UvA-DARE ( Digital Academic Repository ) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS , 2010 .
[9] A. Soran,et al. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[10] I. V. D. van der Ploeg,et al. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] Barbara L. Smith,et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. Begovic,et al. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. , 2004, International journal of radiation oncology, biology, physics.
[13] Kelly K Hunt,et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P. Fayers,et al. The clinical significance of adaptation to changing health: A meta-analysis of response shift , 2006, Quality of Life Research.
[15] U. Chetty,et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.
[16] R. Newcombe,et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer , 2006, Breast Cancer Research and Treatment.
[17] Elizabeth H. Wood,et al. The National Comprehensive Cancer Network (NCCN). , 2004 .
[18] Mark C Kelley,et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.
[19] B. Asselain,et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] E. Rutgers,et al. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] Umberto Veronesi,et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.
[22] Jong-Hyeon Jeong,et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.
[23] E. Rutgers,et al. The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials. , 2001, Surgical oncology clinics of North America.
[24] S. Ménard,et al. Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. , 2000, Annals of surgery.
[25] A. Hart,et al. Primary axillary radiotherapy as axillary treatment in breast‐conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes , 2000, Cancer.
[26] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] B. Asselain,et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer , 1992, The Lancet.